ABT: Abbott Laboratories - Summary | Jitta

Abbott Laboratories

NYSE:ABT

Price
$101.23
Loss Chance
50.1%
5.92JITTA SCORE
219.42%Over Jitta Line
Jitta Ranking
208 / 874
2,490 / 4,194
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (65)
Recent Business Performance (61)
Financial Strength (65)
Return to Shareholders (49)
Competitive Advantage (54)
Jitta Signs
Revenue and EarningConsistent
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Operating MarginInconsistent
Recent Business PerformanceEarning decline 41.29% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
5.92
219.42%
2.36
530.35%
Health Care Equipment
6.68
28.67%
6.60
> 1,000%
7.05
157.54%
COMPANY DESCRIPTION
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company’s Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company’s Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.